| Field | Specification |
|---|---|
| Mfr No | |
| Accession Number | |
| Product Type | |
| Shipping | |
| Species | |
| Storage |
Scientific Background
Nav1.8 is a voltage gated type X, alpha subunit sodium channel which in humans is encoded by the SCN10A gene. It is expressed in nociceptors and has been proposed as a target for the development of new analgesics. Mice deficient in Nav1.8 have deficits in sensing inflammatory pain (initiated by tissue damage/inflammation) and visceral pain (initiated by damage or injury to internal organs) but not neuropathic pain. Native sodium channels are complexes composed of the pore-forming α subunit and an auxiliary β subunit. The sodium channel β2 subunit, encoded by the SCN2B gene, increases current amplitude and surface expression of sodium ion channels.
Product Description
Ion ChannelStable recombinant HEK293 cell line expressing tetracycline-inducible human Nav1.8 (Genbank #NP_006505.2) fused to Green Fluorescent Protein (GFP) [Ex. ~395 nm, 475 nm; em ~510 nm] and C-terminal Streptavidin-Binding Peptide (SBP)-tag, and the human sodium channel β2 subunit (Genbank #NM_004588; SCN2B) with C-terminal FLAG-tag. Nav1.8 is also known as tetrodotoxin-resistant voltage-gated sodium channel type X (SCN10A).
Product Specifications
| Host Cell Line | HEK293 |
|---|---|
| Host Species | Human |
| Transfection Method | Lipofectamine 2000 |
| Format | Each vial contains ~1 x 106 cells in 10% DMSO solution. |
| Harmonized Tariff Code | 3002-5900 |
Quality Control & Validation
✓ Mycoplasma-TestedThe cell line is confirmed for absence of Mycoplasma species using the PCR-based Venor™GeM Mycoplasma Detection kit (Sigma Aldrich).
Usage Notes
See product datasheet for detailed protocol.
Safety & Handling
⚠ Avoid freeze/thaw cycles.
Regulatory Information
License Disclosure
Related Products
Related Products: Cat. #60518, 60507, 60181, 79554
Required Accessories: Cat. #60181,79554
This product is engineered on a HEK293 background (Human origin). The HEK293 host was selected for its compatibility with stable transfection and the target pathway or assay type. Consult the product datasheet for passage number guidance and recommended culture media.
This product is classified as BSL-2. Work must be performed in a certified BSL-2 laboratory by trained personnel. All procedures that may generate aerosols must be conducted inside a Class II Biological Safety Cabinet. Institutional Biosafety Committee (IBC) approval is required before use.
Yes. The cell line is confirmed for absence of Mycoplasma species using the PCR-based Venor™GeM Mycoplasma Detection kit (Sigma Aldrich). We recommend that you independently confirm mycoplasma-negative status after receipt and periodically during routine culture using a validated detection kit.
Store this product at Liquid Nitrogen. Specifically: Immediately upon receipt, store in liquid nitrogen. Transfer cells from dry-ice shipping to the recommended storage immediately upon receipt. Avoid repeated freeze-thaw cycles, which reduce viability and may alter expression characteristics.
Yes, a license is required (Yes). Purchase of this cell line grants a time-limited research-use license for use in your immediate laboratory only. This license does not permit redistribution, sub-licensing, transfer to other institutions, or commercial use. Refer to the License Disclosure section on this page or contact BPS Bioscience for details regarding modifications or commercial licensing.
This cell line contains the following selection marker(s): Nav 1.8: GFP and C-terminal Streptavidin-Binding Peptide (SBP)-tag. β2 subunit: C-terminal FLAG-tag.. The selection marker was used during stable integration to identify and maintain transgene-positive cells. Maintain selection pressure with the appropriate antibiotic during routine culture to preserve transgene expression; refer to the product datasheet for recommended concentrations.
Can't find the cell line you need—or require a custom engineered model for your study? We offer end-to-end support for diverse research needs, including:
- Cell line sourcing and selection (species, tissue, and disease model matching)
- Stable cell line engineering (overexpression, knockdown, knockout via CRISPR/Cas9, shRNA, sgRNA)
- Reporter gene integration (GFP, RFP, luciferase, fluorescent/bioluminescent constructs)
- Genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles)
- Inducible expression systems (Tet-On/Off and regulatable constructs)
- Drug resistance marker selection (puromycin, G418, hygromycin, and others)
- Custom growth and media optimisation for specific assay requirements
- Scale-up production for high-throughput screening campaigns
- Authentication and QC services (STR profiling, mycoplasma testing, viability assessment)
Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
- Catterall, W.A. et al. Pharmacol. Rev. 57 (4): 397-409 (2005).
- Muzny, D.M., et al. Nature 440:1194-1198 (2006).
- Wilson, D.S., et al. Protein Expression and Purification 23 (3): 440-446 (2001).